Purdue Pharma and the family that owns the company have agreed to pay up to $7.4 billion to settle lawsuits filed over the toll OxyContin has taken. The amount agreed upon is more than what was ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice presi ...

Purdue Pharma and the family that owns the company have agreed to pay up to $7.4 billion to settle lawsuits filed over the toll OxyContin has taken. The amount agreed upon is more than what was agreed ...

The money is part of a pending $7.4 billion settlement reached with members of the Sackler family and their company, Purdue Pharma, that still needs court approval. Pennsylvania and 14 other ...

supporting the ISPE Pharma 4.0 holistic control strategy framework.” Industry 4.0-enabled techniques like automation and artificial intelligence can also make process development more cost ...

The pharma industry’s overall push into industry 4.0 for manufacturing, with the aim of streamlining and enabling greater automation through adoption of digital tools, is leading to greater ...

you can compare the attractiveness of information on a website with seeing how a drug works in 3D and realise the potential that virtual reality holds for pharma. 4) Genomics and truly ...